GlassScriptPhysician profile
Thomas A Mcknight
NPI 1679587778
$1,025.47
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $740 · 2020: $262 · 2023: $23.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $23.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $170.11 | 2019 | |
| Pfizer INC. | $137.11 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $97.03 | 2019-2020 | |
| Amarin Pharma, INC. | $90.45 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $59.85 | 2019-2020 | |
| Novo Nordisk INC | $51.61 | 2019 | |
| Allergan, INC. | $47.18 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $40.54 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.92 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $28.36 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.84 | 2019 | |
| Lilly USA, LLC | $27.10 | 2019 | |
| Arbor Pharmaceuticals, INC. | $23.99 | 2019 | |
| Aroa Biosurgery Incorporated | $23.52 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $22.26 | 2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $17.02 | 2019 | |
| Scilex Pharmaceuticals INC. | $16.25 | 2019 | |
| Valeritas, INC. | $16.03 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.61 | 2020 | |
| Sanofi Pasteur INC. | $13.59 | 2019 | |
| Astellas Pharma US INC | $12.34 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.52 | 2020 | |
| Therapeuticsmd, INC. | $11.43 | 2020 | |
| Abbvie INC. | $10.99 | 2019 | |
| Neurocrine Biosciences, INC. | $10.98 | 2020 | |
| Merck Sharp & Dohme LLC | $10.84 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Mcknight listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.